id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2019-E-3295-0006,FDA,FDA-2019-E-3295,Determination of Regulatory Review Period for Purposes of Patent Extension; GALAFOLD,Notice,Determinations,2023-03-22T04:00:00Z,2023,3,2023-03-22T04:00:00Z,2023-05-23T03:59:59Z,2023-03-22T15:03:36Z,2023-05897,0,0,09000064858232a2
FDA-2019-E-3295-0005,FDA,FDA-2019-E-3295,Letter from FDA CDER to U.S. Patent and Trademark Office,Other,Letter(s),2023-03-09T05:00:00Z,2023,3,2023-03-09T05:00:00Z,,2023-03-09T19:48:33Z,,0,0,09000064857854f7